Financhill
Back

Biogen Vs. Axsome Therapeutics Industry Stock Comparison

Sell
50

BIIB
Biogen

Last Price:
$132.75
Seasonality Move:
8.98%
Sell
42

AXSM
Axsome Therapeutics

Last Price:
$104.60
Seasonality Move:
11.24%
Sell
50
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $132.75. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $104.64. The Score for AXSM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $132.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $104.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.65 Buy
Relative Strength Index (14 RSI): 62.66 Buy
Chaikin Money Flow: 1771366 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.88 - 127.56) Buy
Bollinger Bands (100): (123.04 - 145.8) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.35 Sell
Relative Strength Index (14 RSI): 44.34 Sell
Chaikin Money Flow: 318955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.66 - 111.3) Sell
Bollinger Bands (100): (96.98 - 123.36) Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.45 Buy
20-day SMA: 124.08 Buy
50-day SMA: 125.32 Buy
200-day SMA: 157.59 Sell
8-day EMA: 128 Buy
20-day EMA: 125.49 Buy
50-day EMA: 127.2 Buy
200-day EMA: 155.34 Sell

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.43 Sell
20-day SMA: 107.91 Sell
50-day SMA: 109.02 Sell
200-day SMA: 100.65 Buy
8-day EMA: 105.09 Sell
20-day EMA: 106.54 Sell
50-day EMA: 108.5 Sell
200-day EMA: 101.5 Buy

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.05 per share, a decrease this year of $1.55 per share, and an increase next year of $0.64 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.99 per share, an increase this year of $1.51 per share, and an increase next year of $4.87 per share.

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):